Paulo M. Hoff
Department of Gastrointestinal Medical Oncology
University of Texas MD Anderson Cancer Center
Houston
TX 77030
USA
Name/email consistency: high
- A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma. Hoff, P.M., Wolff, R.A., Bogaard, K., Waldrum, S., Abbruzzese, J.L. Jpn. J. Clin. Oncol. (2006)
- Chemotherapy of Metastatic Colorectal Cancer. Saad, E.D., Hoff, P.M. Curr. Treat. Options. Gastroenterol (2005)
- Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer. Hoff, P.M., Saad, E.D., Pazdur, R., Wolff, R., Lassere, Y., Bogaard, K.R., Abbruzzese, J.L. Invest. New. Drugs (2004)
- Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma. Hoff, P.M., Pazdur, R., Lassere, Y., Carter, S., Samid, D., Polito, D., Abbruzzese, J.L. J. Clin. Oncol. (2004)
- Progress in the development of novel treatments for colorectal cancer. Hoff, P.M., Pazdur, R. Oncology (Williston Park, N.Y.) (2004)
- Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?. Hoff, P.M., Ellis, L.M., Abbruzzese, J.L. Oncology (Williston Park, N.Y.) (2004)
- Oxaliplatin-related neurotoxicity: is chelation the solution?. Hoff, P.M. Nature Clinical Practice. Oncology (2004)
- Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. Hoff, P.M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., Maroun, J., Walde, D., Weaver, C., Harrison, E., Burger, H.U., Osterwalder, B., Wong, A.O., Wong, R. J. Clin. Oncol. (2001)
- Phase I trial of i.v. administered tirapazamine plus cyclophosphamide. Hoff, P.M., Saad, E.D., Ravandi-Kashani, F., Czerny, E., Pazdur, R. Anticancer. Drugs (2001)
- Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. Hoff, P.M., Janjan, N., Saad, E.D., Skibber, J., Crane, C., Lassere, Y., Cleary, K.R., Benner, S., Randolph, J., Abbruzzese, J.L., Pazdur, R. J. Clin. Oncol. (2000)
- A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer. Hoff, P.M., Saad, E.D., Janjan, N., Skibber, J., Pazdur, R. Oncology (Williston Park, N.Y.) (2000)